| Drug Name | (Cellcept®( Mycophenolate Mofetil |
|---|---|
| Drug Class |
Immunosuppressant
|
| Risk minimization type |
Patient Card
Direct Healthcare Professional Communication DHPC
Healthcare provider guide
|
| Specialty (Theraputic area) |
Transplant
|
| Risk |
Safety information about: -Teratogenicity
- spontaneous abortions.
- congenital malformations following exposure during pregnancy |
| patient guide |
|
| Health care provider guide |
|
| Dear Healthcare provider letter DHPC |
|